Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T15:35:53.283Z.
Calculation as of: 2026-10-06T15:35:53.283Z.
Quote observation: 2026-10-06T15:30:20.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: dd458a7b7530169a13c79e175a6610edc18df904cb2af71895118b3708428af2
PEG RATIO
N/A
Boundless Bio, Inc.
Market Cap
$57.87M
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Boundless Bio, Inc. (BOLD) | $57.87M | N/A |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.34M | N/A |
| OKYO Pharma Limited (OKYO)vs › | $56.98M | N/A |
| Fractyl Health, Inc. (GUTS)vs › | $59.10M | N/A |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.12M | N/A |
| PDS Biotechnology Corporation (PDSB)vs › | $60.24M | N/A |
| Connect Biopharma Holdings Limited (CNTB)vs › | $60.32M | N/A |
| Spectral AI, Inc. (MDAI)vs › | $55.21M | N/A |
| Adicet Bio, Inc. (ACET)vs › | $61.23M | N/A |
| Aldeyra The (ALDX)vs › | $54.30M | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
